Metformina Rotride Ipca Laboratories Uk (Metformin Hydrochloride)

Metformina Rotride, a biguanide antidiabetic, acts on glucose metabolism pathways to lower blood sugar levels.

• Type 2 diabetes mellitus: improves glycaemic control and reduces HbA1c.
• Prediabetes (impaired glucose tolerance): helps delay progression to overt diabetes.
• Metabolic syndrome: contributes to better fasting glucose and insulin sensitivity.

• Metformin Hydrochloride primarily inhibits mitochondrial respiratory-chain complex I, decreasing hepatic gluconeogenesis. It also enhances peripheral glucose uptake by activating AMP‑activated protein kinase (AMPK), which improves insulin sensitivity in muscle and adipose tissue, leading to lower circulating glucose levels without stimulating insulin secretion.

Metformina Rotride may cause a range of adverse reactions, most of which are related to the gastrointestinal tract, while rare events can be serious.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Diarrhea: frequent loose stools.
• Abdominal discomfort: cramping or pain.
• Metallic taste: altered taste perception.
• Loss of appetite: reduced desire to eat.
• Flatulence: increased gas production.

Serious or Rare Side Effects

• Lactic acidosis: metabolic emergency with high lactate levels.
• Severe skin reactions: such as Stevens‑Johnson syndrome.
• Hepatic dysfunction: elevated liver enzymes or hepatitis.
• Hypoglycaemia (when combined with insulin or sulfonylureas): low blood sugar episodes.
• Vitamin B12 deficiency: anemia or neuropathy with long‑term use.
• Acute pancreatitis: sudden inflammation of the pancreas.

Metformina Rotride requires careful monitoring in several clinical situations to minimise risk.

• Renal function assessment: avoid or adjust dose in patients with impaired kidney function.
• Hepatic impairment: use with caution in liver disease.
• Lactic acidosis risk: discontinue before major surgery or iodinated contrast studies.
• Alcohol consumption: limit intake to reduce acidosis risk.
• Pregnancy and breastfeeding: evaluate benefit‑risk ratio under specialist guidance.
• Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Metformina Rotride can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Iodinated contrast agents: increase risk of lactic acidosis.
• Cimetidine: may raise metformin plasma levels.
• Alcohol: potentiates lactic acidosis.
• Insulin or sulfonylureas: heighten hypoglycaemia risk.
• Certain antiretrovirals (e.g., didanosine): may increase toxicity.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: monitor renal function and potassium.
• Beta‑blockers: may mask hypoglycaemia symptoms.
• NSAIDs: can affect renal clearance.
• Corticosteroids: may raise blood glucose.
• Thyroid hormones: may require dose adjustments.